Related Experiment Video

Updated: Mar 18, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.0K

Declines in the diagnosis of primary progressive MS: A critical change in phenotype or critical measurement error?

Gary R Cutter1, Amber Salter2, Ruth Ann Marrie3

  • 1Department of Biostatistics, School of Public Health, The University of Alabama at Birmingham, Birmingham, AL, USA cutterg@uab.edu.

Multiple Sclerosis (Houndmills, Basingstoke, England)
|July 8, 2016
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.9K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.2K

Related Experiment Videos

Last Updated: Mar 18, 2026

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
08:51

Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla

Published on: February 19, 2021

10.0K
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
11:35

The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool

Published on: June 30, 2014

58.9K
Comprehensive Autopsy Program for Individuals with Multiple Sclerosis
09:41

Comprehensive Autopsy Program for Individuals with Multiple Sclerosis

Published on: July 19, 2019

12.2K

Related Concept Videos

Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

3.0K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.0K
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

603
Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
603

Articles linked to this work by shared authors, journal, and citation graph.

Apathy in normal pressure hydrocephalus: frequency, clinical correlates, and relationship to cerebrospinal fluid removal response.

International review of psychiatry (Abingdon, England)·2026

Assessing the feasibility, theoretical interest, and observed behaviors of adding genetic data to a patient-reported multiple sclerosis registry.

Multiple sclerosis journal - experimental, translational and clinical·2026

A community-validated tool for clinical outcome calculation in multiple sclerosis: Consensus development and scenario-specific recommendations.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Using a hand-held pupillometer to quantify pupil constriction as part of the accommodation reflex.

Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia·2026

Increased functional network connectivity following cognitive rehabilitation in progressive multiple sclerosis with moderate to severe disabilty: findings from the CogEx study.

Journal of neurology·2026

Men's health research priorities in men with multiple sclerosis.

Multiple sclerosis journal - experimental, translational and clinical·2026

Validation of generative artificial intelligence techniques for synthetic data generation in multiple sclerosis research: A comparison with real-world evidence from the Italian multiple sclerosis registry.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Survivor bias and disease progression in observational cohorts in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

How well do junior neurology residents recognize multiple sclerosis? Analysis of the "Close the Loop" resident clinical acumen project.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Myelin oligodendrocyte glycoprotein antibody-associated disease in a patient with AIRE gene dominant-negative mutation.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Neuromyelitis optica spectrum disorder associated with Kabuki syndrome: First reported case and immunopathogenic considerations.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Multiple sclerosis and housing insecurity or forcible displacement: A scoping review.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026

Effects of postmortem interval on myelin integrity in rhesus macaque brain tissue.

Brain pathology (Zurich, Switzerland)·2026

Incidence and Risk Factors for C. difficile Reinfection After Faecal Microbiota Transplantation or Antibiotic Therapy.

Alimentary pharmacology & therapeutics·2026

The Impact of Systemic Treatment With Flunixin Meglumine on the Two Antiproteases Alpha-2-Macroglobulin (A2M) and Alpha-1-Antitrypsin (A1AT) in Equine Plasma and Platelet-Rich Fibrin (PRF).

Veterinary ophthalmology·2026

MUC16 Defines a Fibrotic Endotype With Corticosteroid Insensitivity in Nasal Polyps.

Allergy·2026

Matrix metalloproteinase imaging and survival prospects with aging in murine aortic aneurysm.

EJNMMI research·2026

zDHHC11 is a Common Palmitoyltransferase Regulating Microglia-Mediated Neuroinflammation across Neurodegenerative Diseases.

Neuropharmacology·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us